Victorian era
Before the discovery of antibiotics, a common STI could be deadly
We can’t let antibiotics stop working #NotInOurLifetime
Watch the film
#NotInOurLifetime
Join the Fight Sign the Petition
Demand the government invest more money into discovering new antibiotics before it’s too late
An infected wound? Earache? Routine surgery? Antibiotics have got it covered. But bacteria are rapidly learning to resist antibiotics. This is called Antimicrobial Resistance, or AMR. It’s already a leading cause of death worldwide and it’s getting closer to home every day. Time is running out.
Due to a lack of investment in research, we haven’t discovered a new class of antibiotics for almost 40 years. We urgently need your signature to convince the UK government to invest more money into research, so that scientists can discover effective new antibiotics before it’s too late.
We can’t let antibiotics stop working #NotInOurLifetime
1928
Fleming discovers penicillin, the first antibiotic used in humans
1984
The last discovery of a commercially available antibiotic class
2019
AMR causes 1.27 million deaths in a single year more than HIV/AIDS or malaria
2022
50% increase in gonorrhoea infections, some of which are now untreatable using recommended antibiotics
2023
Sex is a ticking time bomb We need action now
Click to view the timeline
Sex bomb
This is the reality for sex in our lifetime unless we act
The experts ready to help
WHO estimates that in 2020, there were 82.4 million [47.7 million-130.4 million] new cases infected among adolescents and adults aged 15–49 years worldwide, with a global incident rate of 19 (11–29) per 1000 women and 23 (10–43) per 1000 men.
The Ineos Oxford Institute for Antimicrobial Research (IOI) was established at the University of Oxford in January 2021 to rapidly advance research, education and collaboration in search of solutions to tackle the growing threat of antimicrobial resistance.
We are a global educator, joining the dots between scientific researchers, medical communities and the wider public to stop the growing threat of drug-resistant infections.
Without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.